Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue from healthcare workforce services decreased 1.0% year on year, while other revenue decreased 23.8%. The company continued to expand the member base of its healthcare workforce platform, strengthen coordination with its placement services, and enhance the functions of its healthcare DX platform.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥907 million (YoY -9.0%) |
| Operating profit | ¥-118 million |
| Ordinary income | ¥-109 million |
| Profit attributable to owners of the parent | ¥-79 million |
| Net income per share | ¥(14.45) |
| Equity ratio | End of the current fiscal period 73.7 / End of previous period 71.7 |
| Total assets | ¥6,203 million |
| Net assets | ¥4,568 million |
| Cash flows from operating activities | ¥-257,602 thousand |
| Cash flows from investing activities | ¥-33,238 thousand |
| Cash flows from financing activities | ¥-142,297 thousand |
| Cash and cash equivalents at end of period | ¥1,238,783 thousand |
| Full-year earnings forecast | Revenue ¥4,300 million (YoY +2.6%) / Operating profit ¥170 million (YoY +77.3%) / Income before taxes ¥173 million (YoY +59.3%) / Profit for the period attributable to owners of the parent ¥109 million (YoY +95.4%) |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Depreciation and amortization | ¥58,572 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | 0 additions (company name: —), 0 exclusions (company name: —) |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 5,718,600 shares |
| Treasury Shares at Period-End | 228,620 shares |
| Factors Behind Changes in Business Performance | Revenue from healthcare workforce services decreased 1.0% year on year, while other revenue decreased 23.8%. The company continued to expand the member base of its healthcare workforce platform, strengthen coordination with its placement services, and enhance the functions of its healthcare DX platform. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company stated that it was expanding the member base of its healthcare workforce platform, strengthening coordination with its placement services, and enhancing the functions of its healthcare DX platform. However, it did not specify the direct factors behind the quarterly revenue decline and narrower loss.